Management of pregnancies with confirmed cytomegalovirus fetal infection

Fetal Diagnosis and Therapy

Volumn 33, Issue 4, 2013, Pages 203-214

  Benoist, Guillaume ^a,b   Leruez Ville, Marianne ^c   Magny, Jean François ^d   Jacquemard, François ^e   Salomon, Laurent J ^a   Ville, Yves ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Institut de Puériculture   (France)

^e UNIVERSITÉ PARIS OUEST NANTERRE LA DÉFENSE   (France)

Author keywords

Cytomegalovirus; Magnetic resonance imaging; Prenatal diagnosis; Prognosis; Ultrasound

Indexed keywords

AMINOTRANSFERASE; BETA 2 MICROGLOBULIN; CIDOFOVIR; FOSCARNET; GAMMA GLUTAMYLTRANSFERASE; GANCICLOVIR; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VALACICLOVIR;

AMNIOCENTESIS; AMNION FLUID; ASCITES; CONGENITAL INFECTION; CROSS REACTION; CYTOMEGALOVIRUS INFECTION; DISABILITY SEVERITY; DRUG EFFICACY; ECHOGENIC BOWEL; EDEMA; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FETUS BLOOD; GESTATIONAL AGE; HEPATOMEGALY; HUMAN; IMMUNOSTIMULATION; INTRAUTERINE GROWTH RETARDATION; INTRAUTERINE INFECTION; MENSTRUAL CYCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIAL EFFUSION; PLEURA EFFUSION; PREDICTIVE VALUE; PREGNANCY; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRIMARY INFECTION; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SECOND TRIMESTER PREGNANCY; SECONDARY INFECTION; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SEROLOGY; SKIN EDEMA; TERATOGENESIS; THROMBOCYTE COUNT; TREATMENT DURATION; ULTRASOUND; VERTICAL TRANSMISSION; VIRUS GENOME; VIRUS ISOLATION; VIRUS LOAD; CLINICAL TRIAL (TOPIC); CYTOMEGALOVIRUS; DELIVERY; INFECTION RISK; LONG TERM CARE; NEWBORN INFECTION; NEWBORN PERIOD; POLYMERASE CHAIN REACTION; PREGNANCY TERMINATION;

ACYCLOVIR; AMNIOCENTESIS; AMNIOTIC FLUID; ANTIVIRAL AGENTS; CONGENITAL ABNORMALITIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DECISION TREES; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; VALINE;

EID: 84878452301     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000342752     Document Type: Review

References (114)

1. Stagno S: Cytomegalovirus infection: a pediatrician's perspective. Curr Probl Pediatr 1986; 16: 629-667.
2. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA: The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992; 326: 663-667.
3. Demmler GJ: Congenital cytomegalovirus infection. Semin Pediatr Neurol 1994; 1: 36-42.
4. Coll O, Benoist G, Ville Y, Weisman LE, Botet F, Anceschi MM, Greenough A, Gibbs RS, Carbonell-Estrany X: Guidelines on CMV congenital infection. J Perinat Med 2009; 37: 433-445.
5. HAS: Évaluation de l'intérêt du dépistage de l'infection à cytomégalovirus chez la femme enceinte en France. Saint-Denis La Plaine, 2004, 2012.
6. Baccard-Longere M, Freymuth F, Cointe D, Seigneurin JM, Grangeot-Keros L: Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity. Clin Diagn Lab Immunol 2001; 8: 429-431.
7. Revello MG, Genini E, Gorini G, Klersy C, Piralla A, Gerna G: Comparative evaluation of eight commercial human cytomegalovirus IGG avidity assays. J Clin Virol 2010; 48: 255-259.
8. Liesnard C, Donner C, Brancart F, Gosselin F, Delforge ML, Rodesch F: Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol 2000; 95: 881-888.
9. Guerra B, Lazzarotto T, Quarta S, Lanari M, Bovicelli L, Nicolosi A, Landini MP: Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2000; 183: 476-482.
10. Lazzarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP: Prenatal indicators of congenital cytomegalovirus infection. J Pediatr 2000; 137: 90-95.
11. Enders G, Bader U, Lindemann L, Schalasta G, Daiminger A: Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 2001; 21: 362-377.
12. Revello MG, Gerna G: Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002; 15: 680-715.
13. Revello MG, Zavattoni M, Furione M, Baldanti F, Gerna G: Quantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitally infected fetuses. J Clin Microbiol 1999; 37: 3350-3352.
14. Revello MG, Zavattoni M, Sarasini A, Percivalle E, Simoncini L, Gerna G: Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognosis implications for pregnancy. J Infect Dis 1998; 177: 1170-1175.
15. Ducroux A, Cherid S, Benachi A, Ville Y, Leruez-Ville M: Evaluation of new commercial real-time PCR quantification assay for prenatal diagnosis of cytomegalovirus congenital infection. J Clin Microbiol 2008; 46: 2078-2080.
16. Revello MG, Furione M, Zavattoni M, Tassis B, Nicolini U, Fabbri E, Gerna G: Human cytomegalovirus (HCMV) DNAemia in the mother at amniocentesis as a risk factor for iatrogenic HCMV infection of the fetus. J Infect Dis 2008; 197: 593-596.
17. Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, Sanchez PJ, Bernstein DI, Tolan RW Jr, Novak Z, Chowdhury N, Britt WJ, Fowler KB: Saliva polymerase chain reaction assay for cytomegalovirus screening in newborns. N Engl J Med 2011; 364: 2111-2118.
18. Belec L, Brogan TV: Real-time PCR-based testing of saliva for cytomegalovirus at birth. Expert Rev Anti Infect Ther 2011; 9: 1119-1124.
19. Boppana SB, Ross SA, Novak Z, Shimamura M, Tolan RW Jr, Palmer AL, Ahmed A, Michaels MG, Sanchez PJ, Bernstein DI, Britt WJ, Fowler KB: Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA 2010; 303: 1375-1382.
20. Leruez-Ville M, Vauloup-Fellous C, Couderc S, Parat S, Castel C, Avettand-Fenoel V, Guilleminot T, Grangeot-Keros L, Ville Y, Grabar S, Magny JF: Prospective identification of congenital cytomegalovirus infection in newborns using real-time polymerase chain reaction assays in dried blood spots. Clin Infect Dis 2011; 52: 575-581.
21. Vauloup-Fellous C, Ducroux A, Couloigner V, Marlin S, Picone O, Galimand J, Loundon N, Denoyelle F, Grangeot-Keros L, Leruez-Ville M: Evaluation of cytomegalovirus (CMV) DNA quantification in dried blood spots: retrospective study of CMV congenital infection. J Clin Microbiol 2007; 45: 3804-3806.
22. Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA: Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 1992; 11: 93-99.
23. Weller TH, Hanshaw JB: Virologic and clinical observations on cytomegalic inclusion disease. N Engl J Med 1962; 266: 1233-1244.
24. Stagno S, Brasfield DM, Brown MB, Cassell GH, Pifer LL, Whitley RJ, Tiller RE: Infant pneumonitis associated with cytomegalovirus, chlamydia, pneumocystis, and ureaplasma: a prospective study. Pediatrics 1981; 68: 322-329.
25. Stagno S, Pass RF, Thomas JP, Navia JM, Dworsky ME: Defects of tooth structure in congenital cytomegalovirus infection. Pediatrics 1982; 69: 646-648.
26. Anderson KS, Amos CS, Boppana S, Pass R: Ocular abnormalities in congenital cytomegalovirus infection. J Am Optom Assoc 1996; 67: 273-278.
27. Fowler KB, Boppana SB: Congenital cytomegalovirus infection and hearing deficit. J Clin Virol 2006; 35: 226-231.
28. Barbi M, Binda S, Caroppo S, Ambrosetti U, Corbetta C, Sergi P: A wider role for congenital cytomegalovirus infection in sensorineural hearing loss. Pediatr Infect Dis J 2003; 22: 39-42.
29. Barbi M, Binda S, Caroppo S, Primache V: Neonatal screening for congenital cytomegalovirus infection and hearing loss. J Clin Virol 2006; 35: 206-209.
30. Pass RF: Congenital cytomegalovirus infection and hearing loss. Herpes 2005; 12: 50-55.
31. Barbi M, Binda S, Caroppo S, Primache V: Neonatal screening for congenital cytomegalovirus infection and hearing loss. J Clin Virol 2006; 35: 206-209.
32. Binda S, Caroppo S, Dido P, Primache V, Veronesi L, Calvario A, Piana A, Barbi M: Modification of CMV DNA detection from dried blood spots for diagnosing congenital CMV infection. J Clin Virol 2004; 30: 276-279.
33. Stagno S, Pass RF, Dworsky ME, Alford CA Jr: Maternal cytomegalovirus infection and perinatal transmission. Clin Obstet Gynecol 1982; 25: 563-576.
34. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD, Veren DA, Page F, Alford CA: Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 1986; 256: 1904-1908.
35. Yow MD, Williamson DW, Leeds LJ, Thompson P, Woodward RM, Walmus BF, Lester JW, Six HR, Griffiths PD: Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants. Am J Obstet Gynecol 1988; 158: 1189-1195.
36. Boppana SB, Polis MA, Kramer AA, Britt WJ, Koenig S: Virus-specific antibody responses to human cytomegalovirus (HCMV) in human immunodeficiency virus type 1-infected persons with HCMV retinitis. J Infect Dis 1995; 171: 182-185.
37. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ: Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001; 344: 1366-1371.
38. Fowler KB, Stagno S, Pass RF: Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 2003; 289: 1008-1011.
39. Rousseau T, Douvier S, Reynaud I, Laurent N, Bour JB, Durand C, Spagnolo G, Sagot P: Severe fetal cytomegalic inclusion disease after documented maternal reactivation of cytomegalovirus infection during pregnancy. Prenat Diagn 2000; 20: 333-336.
40. Stagno S, Reynolds DW, Huang ES, Thames SD, Smith RJ, Alford CA: Congenital cytomegalovirus infection. N Engl J Med 1977; 296: 1254-1258.
41. Schopfer K, Lauber E, Krech U: Congenital cytomegalovirus infection in newborn infants of mothers infected before pregnancy. Arch Dis Child 1978; 53: 536-539.
42. Daiminger A, Bader U, Enders G: Pre-and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease. BJOG 2005; 112: 166-172.
43. Revello MG, Zavattoni M, Furione M, Lilleri D, Gorini G, Gerna G: Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. J Infect Dis 2002; 186: 553-557.
44. Revello MG, Zavattoni M, Furione M, Fabbri E, Gerna G: Preconceptional primary human cytomegalovirus infection and risk of congenital infection. J Infect Dis 2006; 193: 783-787.
45. Hadar E, Yogev Y, Melamed N, Chen R, Amir J, Pardo J: Periconceptional cytomegalovirus infection: pregnancy outcome and rate of vertical transmission. Prenat Diagn 2010; 30: 1213-1216.
46. Gindes L, Teperberg-Oikawa M, Sherman D, Pardo J, Rahav G: Congenital cytomegalovirus infection following primary maternal infection in the third trimester. BJOG 2008; 115: 830-835.
47. Bodeus M, Hubinont C, Goubau P: Increased risk of cytomegalovirus transmission in utero during late gestation. Obstet Gynecol 1999; 93: 658-660.
48. Ahlfors K, Forsgren M, Ivarsson SA, Harris S, Svanberg L: Congenital cytomegalovirus infection: on the relation between type and time of maternal infection and infant's symptoms. Scand J Infect Dis 1983; 15: 129-138.
49. Steinlin MI, Nadal D, Eich GF, Martin E, Boltshauser EJ: Late intrauterine cytomegalovirus infection: clinical and neuroimaging findings. Pediatr Neurol 1996; 15: 249-253.
50. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S: Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 2006; 35: 216-220.
51. Guerra B, Simonazzi G, Puccetti C, Lanari M, Farina A, Lazzarotto T, Rizzo N: Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2008; 198: 380 e381-387.
52. Malinger G, Lev D, Lerman-Sagie T: Imaging of fetal cytomegalovirus infection. Fetal Diagn Ther 2011; 29: 117-126.
53. De Vries LS, Gunardi H, Barth PG, Bok LA, Verboon-Maciolek MA, Groenendaal F: The spectrum of cranial ultrasound and magnetic resonance imaging abnormalities in congenital cytomegalovirus infection. Neuropediatrics 2004; 35: 113-119.
54. Simonazzi G, Guerra B, Bonasoni P, Pilu G, Lazzarotto T, Santini D, Rizzo N: Fetal cerebral periventricular halo at midgestation: an ultrasound finding suggestive of fetal cytomegalovirus infection. Am J Obstet Gynecol 2010; 202: 599 e591-595.
55. Picone O, Sonigo P, Cordier AG, Vauloup-Fellous C, Benachi A: The in utero natural history of a cytomegalovirus-related fetal cerebral periventricular halo. Prenat Diagn 2010; 30: 1224-1225.
56. Noyola DE, Demmler GJ, Nelson CT, Griesser C, Williamson WD, Atkins JT, Rozelle J, Turcich M, Llorente AM, Sellers-Vinson S, Reynolds A, Bale JF Jr, Gerson P, Yow MD: Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J Pediatr 2001; 138: 325-331.
57. Munro SC, Trincado D, Hall B, Rawlinson WD: Symptomatic infant characteristics of congenital cytomegalovirus disease in Australia. J Paediatr Child Health 2005; 41: 449-452.
58. Ben-Ami T, Yousefzadeh D, Backus M, Reichman B, Kessler A, Hammerman-Rozenberg C: Lenticulostriate vasculopathy in infants with infections of the central nervous system sonographic and Doppler findings. Pediatr Radiol 1990; 20: 575-579.
59. Amir J, Schwarz M, Levy I, Haimi-Cohen Y, Pardo J: Is lenticulostriated vasculopathy a sign of central nervous system insult in infants with congenital CMV infection? Arch Dis Child 2011; 96: 846-850.
60. Engman ML, Lewensohn-Fuchs I, Mosskin M, Malm G: Congenital cytomegalovirus infection: the impact of cerebral cortical malformations. Acta Paediatr 2010; 99: 1344-1349.
61. Bosnjak VM, Dakovic I, Duranovic V, Lujic L, Krakar G, Marn B: Malformations of cortical development in children with congenital cytomegalovirus infection: a study of nine children with proven congenital cytomegalovirus infection. Coll Antropol 2011; 35(suppl 1):229-234.
62. Dhombres F, Nahama-Allouche C, Gelot A, Jouannic JM, de Villemeur TB, Saint-Frison MH, le Pointe HD, Garel C: Prenatal ultrasonographic diagnosis of polymicrogyria. Ultrasound Obstet Gynecol 2008; 32: 951-954.
63. Ortiz JU, Ostermayer E, Fischer T, Kuschel B, Rudelius M, Schneider KT: Severe fetal cytomegalovirus infection associated with cerebellar hemorrhage. Ultrasound Obstet Gynecol 2004; 23: 402-406.
64. Tongsong T, Sukpan K, Wanapirak C, Phadungkiatwattna P: Fetal cytomegalovirus infection associated with cerebral hemorrhage, hydrops fetalis, and echogenic bowel: case report. Fetal Diagn Ther 2008; 23: 169-172.
65. Nigro G, La Torre R, Sali E, Auteri M, Mazzocco M, Maranghi L, Cosmi E: Intraventricular haemorrhage in a fetus with cerebral cytomegalovirus infection. Prenat Diagn 2002; 22: 558-561.
66. Cordier AG, Nedellec S, Benachi A, Frydman R, Picone O: Arguments for an infectious cause of IUGR (in French). J Gynecol Obstet Biol Reprod 2011; 40: 109-115.
67. Chaoui R, Zodan-Marin T, Wisser J: Marked splenomegaly in fetal cytomegalovirus infection: detection supported by three-dimensional power Doppler ultrasound. Ultrasound Obstet Gynecol 2002; 20: 299-302.
68. Simon-Bouy B, Muller F: Hyperechogenic fetal bowel: collaborative study of 682 cases (in French). J Gynecol Obstet Biol Reprod 2003; 32: 459-465.
69. Nigro G, Adler SP, Gatta E, Mascaretti G, Megaloikonomou A, Torre RL, Necozione S: Fetal hyperechogenic bowel may indicate congenital cytomegalovirus disease responsive to immunoglobulin therapy. J Matern Fetal Neonatal Med 2012, E-pub ahead of print.
70. De Oronzo MA: Hyperechogenic fetal bowel: an ultrasonographic marker for adverse fetal and neonatal outcome? J Prenat Med 2011; 5: 9-13.
71. Simon-Bouy B, Satre V, Ferec C, Malinge MC, Girodon E, Denamur E, Leporrier N, Lewin P, Forestier F, Muller F: Hyperechogenic fetal bowel: a large French collaborative study of 682 cases. Am J Med Genet A 2003; 121A:209-213.
72. Jackups R, Mehrad M: Circulating mitotic figures in CMV-associated hydrops fetalis. Blood 2012; 119: 3201.
73. Lujan-Zilbermann J, Lacson A, Gilbert-Barness E, Pomerance HH: Clinico-pathologic conference: newborn with hydrops fetalis caused by CMV infection case report. Pediatr Pathol Mol Med 2003; 22: 481-494.
74. Salmaso R, Franco R, de Santis M, Carollo C, Suma V, Righini A, Manara R, Paternoster DM: Early detection by magnetic resonance imaging of fetal cerebral damage in a fetus with hydrops and cytomegalovirus infection. J Matern Fetal Neonatal Med 2007; 20: 559-561.
75. Barnett CP, Jaeggi E, Han RK, Nevo O, Keating S, Shannon P, Bitnun A, Chitayat D: Unusual cardiac presentation of congenital cytomegalovirus infection. Ultrasound Obstet Gynecol 2010; 35: 119-120.
76. Yinon Y, Yagel S, Tepperberg-Dikawa M, Feldman B, Schiff E, Lipitz S: Prenatal diagnosis and outcome of congenital cytomegalovirus infection in twin pregnancies. BJOG 2006; 113: 295-300.
77. Lazzarotto T, Gabrielli L, Foschini MP, Lanari M, Guerra B, Eusebi V, Landini MP: Congenital cytomegalovirus infection in twin pregnancies: viral load in the amniotic fluid and pregnancy outcome. Pediatrics 2003; 112:e153-e157.
78. La Torre R, Nigro G, Mazzocco M, Best AM, Adler SP: Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin Infect Dis 2006; 43: 994-1000.
79. Picone O, Vauloup-Fellous C, Cordier AG, Grangeot-Keros L, Frydman R, Senat MV: Late onset of ultrasound abnormalities in a case of periconceptional congenital cytomegalovirus infection. Ultrasound Obstet Gynecol 2008; 31: 481-483.
80. Carletti A, Colleoni GG, Perolo A, Simonazzi G, Ghi T, Rizzo N, Pilu G: Prenatal diagnosis of cerebral lesions acquired in utero and with a late appearance. Prenat Diagn 2009; 29: 389-395.
81. Benoist G, Salomon LJ, Jacquemard F, Daffos F, Ville Y: The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus. BJOG 2008; 115: 823-829.
82. Farkas N, Hoffmann C, Ben-Sira L, Lev D, Schweiger A, Kidron D, Lerman-Sagie T, Malinger G: Does normal fetal brain ultrasound predict normal neurodevelopmental outcome in congenital cytomegalovirus infection? Prenat Diagn 2011; 31: 360-366.
83. Barkovich AJ, Lindan CE: Congenital cytomegalovirus infection of the brain: imaging analysis and embryologic considerations. AJNR Am J Neuroradiol 1994; 15: 703-715.
84. Soussotte C, Maugey-Laulom B, Carles D, Diard F: Contribution of transvaginal ultrasonography and fetal cerebral MRI in a case of congenital cytomegalovirus infection. Fetal Diagn Ther 2000; 15: 219-223.
85. Malinger G, Lev D, Zahalka N, Ben Aroia Z, Watemberg N, Kidron D, Sira LB, Lerman-Sagie T: Fetal cytomegalovirus infection of the brain: the spectrum of sonographic findings. AJNR Am J Neuroradiol 2003; 24: 28-32.
86. Garel C, Chantrel E, Brisse H, Elmaleh M, Luton D, Oury JF, Sebag G, Hassan M: Fetal cerebral cortex: normal gestational landmarks identified using prenatal MRI. AJNR Am J Neuroradiol 2001; 22: 184-189.
87. Benoist G, Salomon LJ, Mohlo M, Suarez B, Jacquemard F, Ville Y: Cytomegalovirus-related fetal brain lesions: comparison between targeted ultrasound examination and magnetic resonance imaging. Ultrasound Obstet Gynecol 2008; 32: 900-905.
88. Picone O, Simon I, Benachi A, Brunelle F, Sonigo P: Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection. Prenat Diagn 2008; 28: 753-758.
89. Lipitz S, Hoffmann C, Feldman B, Tepperberg-Dikawa M, Schiff E, Weisz B: Value of prenatal ultrasound and magnetic resonance imaging in assessment of congenital primary cytomegalovirus infection. Ultrasound Obstet Gynecol 2010; 36: 709-717.
90. Manara R, Balao L, Baracchini C, Drigo P, D'Elia R, Ruga EM: Brain magnetic resonance findings in symptomatic congenital cytomegalovirus infection. Pediatr Radiol 2011; 41: 962-970.
91. Rivera LB, Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF: Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection. Pediatrics 2002; 110: 762-767.
92. Gouarin S, Gault E, Vabret A, Cointe D, Rozenberg F, Grangeot-Keros L, Barjot P, Garbarg-Chenon A, Lebon P, Freymuth F: Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. J Clin Microbiol 2002; 40: 1767-1772.
93. Picone O, Costa JM, Leruez-Ville M, Ernault P, Olivi M, Ville Y: Cytomegalovirus (CMV) glycoprotein B genotype and CMV DNA load in the amniotic fluid of infected fetuses. Prenat Diagn 2004; 24: 1001-1006.
94. Goegebuer T, Van Meensel B, Beuselinck K, Cossey V, Van Ranst M, Hanssens M, Lagrou K: Clinical predictive value of real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples. J Clin Microbiol 2009; 47: 660-665.
95. Bale JF Jr, Murph JR, Demmler GJ, Dawson J, Miller JE, Petheram SJ: Intrauterine cytomegalovirus infection and glycoprotein B genotypes. J Infect Dis 2000; 182: 933-936.
96. Arav-Boger R, Battaglia CA, Lazzarotto T, Gabrielli L, Zong JC, Hayward GS, Diener-West M, Landini MP: Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. J Infect Dis 2006; 194: 464-473.
97. Lanari M, Lazzarotto T, Venturi V, Papa I, Gabrielli L, Guerra B, Landini MP, Faldella G: Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics 2006; 117:e76-e83.
98. Revello MG, Zavattoni M, Baldanti F, Sarasini A, Paolucci S, Gerna G: Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. J Clin Virol 1999; 14: 57-66.
99. Fabbri E, Revello M, Furione M, Zavattoni M, Lilleri D, Tassis B, Quarenghi A, Rustico M, Nicolini U, Ferrazzi E, Gerna G: Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood. BJOG 2011; 118: 448-456.
100. Boppana SB, Fowler KB, Vaid Y, Hedlund G, Stagno S, Britt WJ, Pass RF: Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 1997; 99: 409-414.
101. Kang JW, Kim GN, Kim SY, Kim HJ, Park ES, Kim JY, Lee YH: Clinical and radiologic evaluation of cytomegalovirus-induced thrombocytopenia in infants between 1 and 6 months of age. Korean J Hematol 2010; 45: 29-35.
102. Dreux S, Rousseau T, Gerber S, Col JY, Dommergues M, Muller F: Fetal serum - 2-microglobulin as a marker for fetal infectious diseases. Prenat Diagn 2006; 26: 471-474.
103. Duchatel F, Oury JF, Mennesson B, Muray JM: Complications of diagnostic ultrasound-guided percutaneous umbilical blood sampling: analysis of a series of 341 cases and review of the literature. Eur J Obstet Gynecol Reprod Biol 1993; 52: 95-104.
104. Jacquemard F Yamamoto M, Costa JM, Romand S, Jacz-Aigrain E, Daffos F, Ville Y: Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 2007; 114: 1113-1121.
105. Moise KJ, Wolfe H: Treatment of second trimester fetal cytomegalovirus infection with maternal hyperimmune globulin. Prenat Diagn 2008; 28: 264-265.
106. Moxley K, Knudtson EJ: Resolution of hydrops secondary to cytomegalovirus after maternal and fetal treatment with human cytomegalovirus hyperimmune globulin. Obstet Gynecol 2008; 111: 524-526.
107. Nigro G, Adler SP, La Torre R, Best AM: Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005; 353: 1350-1362.
108. Nigro G, Torre RL, Pentimalli H, Taverna P, Lituania M, de Tejada BM, Adler SP: Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy. Prenat Diagn 2008; 28: 512-517.
109. Nigro G, Adler SP, Parruti G, Anceschi MM, Coclitle E, Pezone I, Di Renzo GC: Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy-a case-control study of the outcome in children. J Infect Dis 2012; 205: 215-227.
110. Malinger G, Ben-Sira L, Lev D, Ben-Aroya Z, Kidron D, Lerman-Sagie T: Fetal brain imaging: a comparison between magnetic resonance imaging and dedicated neurosonography. Ultrasound Obstet Gynecol 2004; 23: 333-340.
111. Malinger G, Kidron D, Schreiber L, Ben-Sira L, Hoffmann C, Lev D, Lerman-Sagie T: Prenatal diagnosis of malformations of cortical development by dedicated neurosonography. Ultrasound Obstet Gynecol 2007; 29: 178-191.
112. Malinger G, Lev D, Lerman-Sagie T: Is fetal magnetic resonance imaging superior to neurosonography for detection of brain anomalies? Ultrasound Obstet Gynecol 2002; 20: 317-321.
113. Malinger G, Lev D, Lerman-Sagie T: Normal and abnormal fetal brain development during the third trimester as demonstrated by neurosonography. Eur J Radiol 2006; 57: 226-232.
114. Salomon LJ, Garel C: Magnetic resonance imaging examination of the fetal brain. Ultrasound Obstet Gynecol 2007; 30: 1019-1032.